CURRENT AFFAIRS

Detailed explanation-1: -Following positive data from a large phase 2/3 clinical trial, marketing authorisation was granted by the Drugs Controller General of India on July 12, 2022, for female and male individuals aged 9–26 years, with the vaccine officially launched on Sept 1.

Detailed explanation-2: -Serum Institute of India CEO Adar Poonawalla. NEW DELHI : On the occasion of National Girl Child Day, the Serum Institute of India on Tuesday launched the first indigenously developed human papillomavirus vaccine (HPV)–“CERVAVAC, ” against the cervical cancer in women.

Detailed explanation-3: -Since HPV vaccination was first recommended in 2006, infections with HPV types that cause most HPV cancers and genital warts have dropped 88% among teen girls and 81% among young adult women.

Detailed explanation-4: -Currently, there are two types of HPV vaccines available in India. Both of them are licensed globally. The first one is a quadrivalent vaccine called Gardasil, while the second is a bivalent one by the name Cervarix.